|
Volumn 7, Issue 6, 2001, Pages 1487-1489
|
The battle between tumor suppressors: Is gene therapy using p16INK4a more efficacious than p53 for treatment of ovarian carcinoma?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIN D;
CYCLIN DEPENDENT KINASE 2;
CYCLIN DEPENDENT KINASE 4;
CYCLIN E;
PROTEIN P16;
PROTEIN P21;
PROTEIN P53;
RETINOBLASTOMA PROTEIN;
ARTICLE;
CANCER INHIBITION;
GENE EXPRESSION REGULATION;
GENE THERAPY;
HUMAN;
OVARY CARCINOMA;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SIGNAL TRANSDUCTION;
TUMOR SUPPRESSOR GENE;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
FEMALE;
GENE THERAPY;
GENES, P53;
HUMANS;
MODELS, BIOLOGICAL;
OVARIAN NEOPLASMS;
TRANSGENES;
|
EID: 0034901271
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (23)
|